[go: up one dir, main page]

JP6834376B2 - Surfactant composition - Google Patents

Surfactant composition Download PDF

Info

Publication number
JP6834376B2
JP6834376B2 JP2016219392A JP2016219392A JP6834376B2 JP 6834376 B2 JP6834376 B2 JP 6834376B2 JP 2016219392 A JP2016219392 A JP 2016219392A JP 2016219392 A JP2016219392 A JP 2016219392A JP 6834376 B2 JP6834376 B2 JP 6834376B2
Authority
JP
Japan
Prior art keywords
mass
aqueous solution
taurine
content
sodium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016219392A
Other languages
Japanese (ja)
Other versions
JP2017095451A (en
Inventor
昌彦 嶋田
昌彦 嶋田
藤田 博也
博也 藤田
諭 松尾
諭 松尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Publication of JP2017095451A publication Critical patent/JP2017095451A/en
Application granted granted Critical
Publication of JP6834376B2 publication Critical patent/JP6834376B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Description

本発明は、界面活性剤組成物に関し、例えば水溶液などの液状の界面活性剤組成物に関する。 The present invention relates to a surfactant composition, for example, a liquid surfactant composition such as an aqueous solution.

アシルアミノ酸系界面活性剤は、皮膚や毛髪に対する刺激性が低く、起泡性が高いという優れた使用感を有することから、頭皮、頭髪やボディ用洗浄剤といった身体用洗浄剤の主要成分、または補助成分として汎用されている。このアシルアミノ酸系界面活性剤の中でもN−アシルメチルタウリンのタウリン塩は、泡の持続性に優れ、また、ヘアシャンプーに使用した場合、洗浄後の毛髪にまとまりを与え、保湿効果も高いことから、特に有用であることが知られている。
N−アシルメチルタウリンのタウリン塩を含有する身体用洗浄剤等の製剤は、一般に泡質や使用感を考慮し、まず複数の界面活性剤と組み合わせて配合した後、必要に応じて、製剤の安定性に寄与する粘度調整剤、ハイドロトロープ剤、キレート剤、防腐剤や、嗜好性にあわせて香料等をさらに配合して製造されている。
Acylamino acid-based surfactants have an excellent feeling of use that they are less irritating to the skin and hair and have high foaming properties. Therefore, they are the main components of body cleansers such as scalp, hair and body cleansers, or It is widely used as an auxiliary ingredient. Among these acylamino acid-based surfactants, the taurine salt of N-acylmethyltaurine has excellent foam durability, and when used in a hair shampoo, it gives the hair after washing a cohesiveness and has a high moisturizing effect. , Is known to be particularly useful.
Formulations such as body cleansers containing the taurine salt of N-acylmethyl taurine are generally blended in combination with a plurality of surfactants in consideration of foam quality and usability, and then, if necessary, It is manufactured by further blending a viscosity modifier, a hydrotrope, a chelating agent, a preservative, and a fragrance according to the taste, which contribute to stability.

N−アシルメチルタウリンのタウリン塩を複数の界面活性剤と配合する段階では、製剤を調製する際の取り扱い性、生産効率、輸送コストなどの理由から、N−アシルメチルタウリンのタウリン塩の有効成分濃度をできるだけ高くした界面活性剤組成物とすることが望ましい。
しかしながら、N−アシルメチルタウリンのタウリン塩を含む界面活性剤組成物では、通常、有効成分濃度が15質量%を超えると、20℃程度の室温においてもN−アシルメチルタウリンのタウリン塩が析出し、水溶液の固化または分離を生じることがあり、水溶液の透明性が失われることがある。また、冬季のような低温下で固化した場合、室温に戻しても、同様に、水溶液の固化または分離によって、水溶液の透明性が失われることがある。このような場合には、身体用洗浄剤等の製剤に配合するなどの取り扱い時に加温や振とう等の操作が必要となり、作業性やハンドリング性に支障をきたすという課題があった。
At the stage of blending the taurine salt of N-acylmethyl taurine with multiple surfactants, the active ingredient of the taurine salt of N-acylmethyl taurine is used for reasons such as handleability, production efficiency, and transportation cost when preparing the preparation. It is desirable to obtain a surfactant composition having a concentration as high as possible.
However, in a surfactant composition containing a taurine salt of N-acylmethyl taurine, usually, when the concentration of the active ingredient exceeds 15% by mass, the taurine salt of N-acylmethyl taurine is precipitated even at room temperature of about 20 ° C. , Solidification or separation of the aqueous solution may occur, and the transparency of the aqueous solution may be lost. Further, when solidified at a low temperature such as in winter, the transparency of the aqueous solution may be lost due to the solidification or separation of the aqueous solution even when the temperature is returned to room temperature. In such a case, there is a problem that operations such as heating and shaking are required at the time of handling such as blending in a preparation such as a body cleanser, which hinders workability and handleability.

このような課題はN−アシルメチルタウリンのタウリン塩の反応時に生じる副成分に由来するものと推測される。つまり、N−アシルメチルタウリンのタウリン塩は、特許文献1および特許文献2に示されているように、一般的にN−アシルメチルタウリンのナトリウム塩等をタウリン塩に塩交換することで製造され、この際に副生成物として生成される塩化ナトリウムが共存することによる塩析によって上記課題が生じるものと推測される。
塩化ナトリウムがこのように共存する理由としては、特許文献1の実施例に記載されているように、原料となるN−アシルメチルタウリン塩含有生成物に、アシル化剤として使用される脂肪酸クロリド由来の塩化ナトリウムが含まれることによる場合や、特許文献2の実施例に記載されているように、反応工程中に塩酸を使用した際に塩化ナトリウムが副生する場合が考えられる。
しかしながら、N−アシルメチルタウリンのタウリン塩を含む界面活性剤組成物に関して、室温における水溶液の固化や分離を防ぐ提案はこれまでなされておらず、上記課題は未だ解決されていない。
It is presumed that such a problem is derived from a subcomponent generated during the reaction of the taurine salt of N-acylmethyltaurine. That is, the taurine salt of N-acylmethyl taurine is generally produced by exchanging a sodium salt or the like of N-acylmethyl taurine with a taurine salt, as shown in Patent Documents 1 and 2. At this time, it is presumed that the above-mentioned problems occur due to salting out due to the coexistence of sodium chloride produced as a by-product.
The reason why sodium chloride coexists in this way is that, as described in Examples of Patent Document 1, the N-acylmethyl taurine salt-containing product as a raw material is derived from the fatty acid chloride used as an acylating agent. It is conceivable that sodium chloride is contained in the above, or sodium chloride is produced as a by-product when hydrochloric acid is used during the reaction step as described in Examples of Patent Document 2.
However, regarding the surfactant composition containing the taurine salt of N-acylmethyltaurine, no proposal has been made to prevent the solidification or separation of the aqueous solution at room temperature, and the above-mentioned problems have not yet been solved.

一方、液体衣料用洗浄剤や液体食器用洗浄剤に使用される、N−アシルメチルタウリンのタウリン塩以外の他の界面活性剤組成物については、室温における水溶液の固化や分離を抑えることを目的とした技術が種々開発されている。
例えば、特許文献3には、アニオン界面活性剤とキラヤ抽出物と1,3−ブチレングリコール等のポリオールを含有する組成物が提案されている。また特許文献4には、アミンオキシドとポリエチレングリコールを含有する組成物が提案されている。また特許文献5には、ポリオキシアルキレンアルキルエーテル硫酸エステル塩とエタノールを含有する組成物が提案されている。さらに特許文献6には、α−スルホ脂肪酸アルキルエステル塩と2−エチルヘキサノール等の分岐鎖状アルコールを含有する組成物が提案されている。
On the other hand, with respect to surfactant compositions other than the taurine salt of N-acylmethyl taurine used in liquid clothing cleaning agents and liquid tableware cleaning agents, the purpose is to suppress solidification and separation of the aqueous solution at room temperature. Various technologies have been developed.
For example, Patent Document 3 proposes a composition containing an anionic surfactant, a Quillaia extract, and a polyol such as 1,3-butylene glycol. Further, Patent Document 4 proposes a composition containing an amine oxide and polyethylene glycol. Further, Patent Document 5 proposes a composition containing a polyoxyalkylene alkyl ether sulfate ester salt and ethanol. Further, Patent Document 6 proposes a composition containing an α-sulfofatty acid alkyl ester salt and a branched chain alcohol such as 2-ethylhexanol.

しかしながら、上記特許文献3〜6に示される従来技術では、室温におけるN−アシルメチルタウリンのタウリン塩含有界面活性剤組成物については、固化や分離を防ぐという目的において未だ十分ではなかった。具体的には、特許文献3で配合されている1,3−ブチレングリコール等のポリオールを使用することにより、ポリオールの種類によっては20℃程度の室温における水溶液の固化や分離を防ぐことは可能であるが、冬季のような低温下で固化した場合、室温に戻してもN−アシルメチルタウリンのタウリン塩含有界面活性剤組成物は分離した状態になり、作業性やハンドリング性の改善にはつながらなかった。また、特許文献4、5および6で配合されているポリエチレングリコール、エタノールおよび分岐鎖状アルコールを使用しても、室温における水溶液の固化や分離を防ぐことはできなかった。 However, in the prior art shown in Patent Documents 3 to 6, the taurine salt-containing surfactant composition of N-acylmethyl taurine at room temperature has not yet been sufficient for the purpose of preventing solidification and separation. Specifically, by using a polyol such as 1,3-butylene glycol compounded in Patent Document 3, it is possible to prevent the aqueous solution from solidifying or separating at room temperature of about 20 ° C. depending on the type of polyol. However, when solidified at a low temperature such as in winter, the taurine salt-containing surfactant composition of N-acylmethyl taurine remains in a separated state even when the temperature is returned to room temperature, which leads to improvement in workability and handleability. There wasn't. Further, even if polyethylene glycol, ethanol and branched chain alcohol blended in Patent Documents 4, 5 and 6 were used, solidification and separation of the aqueous solution at room temperature could not be prevented.

特許2003−286499号公報Japanese Patent No. 2003-286499 特開2002−1086号公報JP-A-2002-1086 特開2014−136701号公報Japanese Unexamined Patent Publication No. 2014-136701 特許2011−137056号公報Japanese Patent No. 2011-137056 特開2009−114239号公報JP-A-2009-114239 特開2008−94942号公報Japanese Unexamined Patent Publication No. 2008-9942

本発明の目的は、N−アシルメチルタウリンのタウリン塩を含む界面活性剤組成物において、20℃程度の室温でN−アシルメチルタウリンのタウリン塩が析出し難く透明であり、低温下で固化しても室温下に戻すと再び透明になる復元性を有する界面活性剤組成物を提供することである。 An object of the present invention is that in a surfactant composition containing a taurine salt of N-acylmethyl taurine, the taurine salt of N-acylmethyl taurine is difficult to precipitate at room temperature of about 20 ° C. and is transparent and solidifies at a low temperature. However, it is an object of the present invention to provide a surfactant composition having a restoring property which becomes transparent again when the temperature is returned to room temperature.

本発明者らは、上記課題を解決するために鋭意検討を行った結果、N−アシルメチルタウリンのタウリン塩と、特定の有機酸とを組み合わせることにより、上記の目的を達成するに至った。 As a result of diligent studies to solve the above problems, the present inventors have achieved the above object by combining a taurine salt of N-acylmethyl taurine with a specific organic acid.

すなわち本発明は、(A)下記一般式(1)で示されるN−アシルメチルタウリンのタウリン塩を15〜35質量%、(B)炭素数6以下のジカルボン酸を0.5〜5質量%含有し、塩化ナトリウムの含有量が2質量%以下であることを特徴とする界面活性剤組成物である。
CON(CH)CHCHSO ・・・(1)
(RCOは炭素数8〜24のアシル基、XはHCHCHSO であり、Mはアルカリ金属イオンまたは有機アンモニウムである。)
That is, the present invention, (A) 15 to 35 wt% taurine salt of N--acylmethyltaurine represented by the following general formula (1), 0.5 to 5 mass (B) having 6 or less of dicarboxylic acid carbon The surfactant composition is characterized by having a% content and a sodium chloride content of 2% by mass or less.
R 1 CON (CH 3 ) CH 2 CH 2 SO 3 - X + ... (1)
(R 1 CO is an acyl group having 8 to 24 carbon atoms, X + is H 3 N + CH 2 CH 2 SO 3 - M + , and M + is an alkali metal ion or organic ammonium.)

本発明の界面活性剤組成物は、N−アシルメチルタウリンのタウリン塩を含有する界面活性剤組成物であって、20℃程度の室温でN−アシルメチルタウリンのタウリン塩が析出し難く透明であり、低温下で固化しても室温下に戻すと再び透明になる復元性を有する。したがって、本発明によれば、取り扱い時に加温や振とう等の操作が不要となり、作業性やハンドリング性が良好であるという効果が得られる。 The surfactant composition of the present invention is a surfactant composition containing a taurine salt of N-acylmethyl taurine, and is transparent so that the taurine salt of N-acylmethyl taurine does not easily precipitate at room temperature of about 20 ° C. It has the resilience that even if it solidifies at low temperature, it becomes transparent again when it is returned to room temperature. Therefore, according to the present invention, it is not necessary to perform operations such as heating and shaking during handling, and it is possible to obtain an effect that workability and handleability are good.

以下、本発明の実施形態を説明する。
本発明の界面活性剤組成物は、以下に説明する(A)成分および(B)成分を含有する。
Hereinafter, embodiments of the present invention will be described.
The surfactant composition of the present invention contains the components (A) and (B) described below.

〔(A)成分〕
本発明に用いられる(A)成分は、下記一般式(1)で表されるN−アシルメチルタウリンのタウリン塩である。
CON(CH)CHCHSO ・・・(1)
[(A) component]
The component (A) used in the present invention is a taurine salt of N-acylmethyl taurine represented by the following general formula (1).
R 1 CON (CH 3 ) CH 2 CH 2 SO 3 - X + ... (1)

式中RCOは炭素数8〜24のアシル基であり、好ましくは炭素数8〜18のアシル基である。具体的には、カプリロイル基、カプロイル基、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、オレオイル基、ベヘノイル基であり、これらアシル基の二種以上を含む混合アシル基を使用することもできる。混合アシル基としては、例えば、ココイル基やパーム核油脂肪酸アシル基等が挙げられる。ココイル基に含まれる各アシル基の代表的な含有比率は、C8:C10:C12:C14:C16:C18=5:6:55:17:10:7(質量比)である。またパーム核油脂肪酸アシル基に含まれる各アシル基の代表的な含有比率は、C8:C10:C12:C14:C16:C18=3:7:47:14:9:20(質量比)である。
成分(A)におけるアシル基は、室温における析出のし難さから、カプリロイル基、カプロイル基、ラウロイル基、ミリストイル基、オレオイル基、ココイル基が好ましく、より好ましくはココイル基である。
In the formula, R 1 CO is an acyl group having 8 to 24 carbon atoms, preferably an acyl group having 8 to 18 carbon atoms. Specifically, it is a capriloyl group, a caproyl group, a lauroyl group, a myristoylation group, a palmitoyl group, a stearoyl group, an oleoil group, a behenoyl group, and a mixed acyl group containing two or more of these acyl groups can also be used. .. Examples of the mixed acyl group include a coconut group and a palm kernel oil fatty acid acyl group. The typical content ratio of each acyl group contained in the cocoyl group is C8: C10: C12: C14: C16: C18 = 5: 6: 55: 17: 10: 7 (mass ratio). The typical content ratio of each acyl group contained in the palm kernel oil fatty acid acyl group is C8: C10: C12: C14: C16: C18 = 3: 7: 47: 14: 9: 20 (mass ratio). ..
The acyl group in the component (A) is preferably a capryloyl group, a caproyl group, a lauroyl group, a myristoylation group, an oleoil group, or a cocoyl group, and more preferably a cocoyl group, because it is difficult to precipitate at room temperature.

式中XはHCHCHSO で示される。Mはアルカリ金属イオンまたは有機アンモニウムである。具体的には、アルカリ金属として、例えば、ナトリウム、カリウム等が挙げられ、また有機アンモニウムとしては、例えば、トリエタノールアミン、アルギニン、リジン、ヒスチジン等が挙げられる。X中のMは、室温における析出のし難さから、上記のいずれのアルカリ金属イオンまたは有機アンモニウムであっても良い。 In the formula, X + is represented by H 3 N + CH 2 CH 2 SO 3 M + . M + is an alkali metal ion or organic ammonium. Specifically, examples of the alkali metal include sodium, potassium and the like, and examples of the organic ammonium include triethanolamine, arginine, lysine, histidine and the like. M + in X + may be any of the above alkali metal ions or organic ammonium because it is difficult to precipitate at room temperature.

成分(A)は、本発明の界面活性剤組成物中に、1種または2種以上を用いることができる。成分(A)の含有量は、界面活性剤組成物中、15〜35質量%であり、好ましくは18〜30質量%、特に好ましくは20〜25質量%である。含有量が少なすぎると、製剤に利用する際の取り扱い性、生産効率、輸送コストなどの点で不利となることがある。含有量が多すぎると、室温で組成物の固化または分離が起こり易くなることがある。 As the component (A), one kind or two or more kinds can be used in the surfactant composition of this invention. The content of the component (A) is 15 to 35% by mass, preferably 18 to 30% by mass, and particularly preferably 20 to 25% by mass in the surfactant composition. If the content is too low, it may be disadvantageous in terms of handleability, production efficiency, transportation cost, etc. when used in a formulation. If the content is too high, solidification or separation of the composition may occur easily at room temperature.

〔(B)成分〕
本発明に用いられる(B)成分は、炭素数6以下のヒドロキシ酸、または炭素数6以下のジカルボン酸であり、炭素数6以下のヒドロキシ酸および炭素数6以下のジカルボン酸を併せて用いてもよい。
炭素数6以下のヒドロキシ酸としては、例えば、グリコール酸、乳酸、タルトロン酸、グリセリン酸、リンゴ酸、酒石酸、クエン酸、イソクエン酸、パントイン酸、メバロン酸、ロイシン酸等が挙げられ、1種または2種以上を用いることができる。
炭素数6以下のジカルボン酸としては、例えば、シュウ酸、マロン酸、コハク酸、グルタル酸等が挙げられ、1種または2種以上を用いることができる。
ヒドロキシ酸およびジカルボン酸の炭素数が大きすぎると、組成物における溶解性が低く、使用に適さないことがある。
成分(B)は、室温における析出のし難さ、および復元性から、炭素数6以下のヒドロキシ酸または炭素数6以下のジカルボン酸であればいずれでも良いが、身体洗浄剤に使用される場合を考えると、化粧品に一般的に使用されるもの、例えば、グリコール酸、乳酸、リンゴ酸、酒石酸、クエン酸、シュウ酸、マロン酸およびコハク酸が好ましく、さらに界面活性剤との相溶性の点から、乳酸、クエン酸、マロン酸が特に好ましく、クエン酸が最も好ましい。
[Component (B)]
The component (B) used in the present invention is a hydroxy acid having 6 or less carbon atoms or a dicarboxylic acid having 6 or less carbon atoms, and a hydroxy acid having 6 or less carbon atoms and a dicarboxylic acid having 6 or less carbon atoms are used in combination. May be good.
Examples of the hydroxy acid having 6 or less carbon atoms include glycolic acid, lactic acid, tartronic acid, glyceric acid, malic acid, tartaric acid, citric acid, isocitric acid, pantoic acid, mevalonic acid, leucic acid and the like. Two or more types can be used.
Examples of the dicarboxylic acid having 6 or less carbon atoms include oxalic acid, malonic acid, succinic acid, glutaric acid and the like, and one or more of them can be used.
If the hydroxy and dicarboxylic acids have too many carbon atoms, they may have low solubility in the composition and may not be suitable for use.
The component (B) may be any hydroxy acid having 6 or less carbon atoms or a dicarboxylic acid having 6 or less carbon atoms because of the difficulty of precipitation at room temperature and the recoverability, but when used in a body cleaning agent. Considering the above, those commonly used in cosmetics, for example, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, oxalic acid, malonic acid and succinic acid are preferable, and compatibility with surfactants is also preferable. Therefore, lactic acid, citric acid, and malic acid are particularly preferable, and citric acid is most preferable.

成分(B)の含有量は、界面活性剤組成物中、0.1 〜5質量%であり、好ましくは0.3〜3質量%、特に好ましくは0.5〜1.5質量%である。含有量が少なすぎると、室温で界面活性剤組成物の固化または分離が起こり易くなることがある。含有量が多すぎると、低温下で固化した後に室温で保存しても復元性が得られ難くなり、組成物が透明になり難くなることがある。 The content of the component (B) is 0.1 to 5% by mass, preferably 0.3 to 3% by mass, and particularly preferably 0.5 to 1.5% by mass in the surfactant composition. .. If the content is too low, solidification or separation of the surfactant composition may occur easily at room temperature. If the content is too high, it may be difficult to obtain resilience even when stored at room temperature after solidifying at a low temperature, and it may be difficult for the composition to become transparent.

本発明の界面活性剤組成物には、成分(A)のN−アシルメチルタウリンのタウリン塩を調製する際に生じる副生物に由来した塩化ナトリウムを含有することがある。
本発明においては塩化ナトリウムの含有量が2質量%以下、好ましくは1.5質量%以下、特に好ましくは1質量%以下である。塩化ナトリウムの含有量が多すぎると、室温で組成物の固化または分離が起こることがある。なお、塩化ナトリウムの含有量の下限値は、可及的に0質量%に近いことが好ましく、0質量%が特に好ましい。
本発明の界面活性剤組成物中に含有される塩化ナトリウムの含有量を2質量%以下に調整する方法としては、例えば、N−アシルメチルタウリンのタウリン塩を含有する生成物を逆浸透膜法や電気透析法、または溶剤法により脱塩処理する方法等が挙げられる。
The surfactant composition of the present invention may contain sodium chloride derived from a by-product generated in the preparation of the taurine salt of N-acylmethyltaurine as the component (A).
In the present invention, the content of sodium chloride is 2% by mass or less, preferably 1.5% by mass or less, and particularly preferably 1% by mass or less. If the content of sodium chloride is too high, solidification or separation of the composition may occur at room temperature. The lower limit of the sodium chloride content is preferably as close to 0% by mass as possible, and particularly preferably 0% by mass.
As a method for adjusting the content of sodium chloride contained in the surfactant composition of the present invention to 2% by mass or less, for example, a reverse osmosis membrane method is used for a product containing a taurine salt of N-acylmethyltaurine. , Electrodialysis method, solvent method, and the like.

なお、界面活性剤組成物中に含有される塩化ナトリウムの含有量は、例えば、アルコール不溶分により測定することができ、具体的には次の方法により測定することができる。
まず、界面活性剤組成物を三角フラスコに量りとり、これにイソプロピルアルコールを加えた後、還流冷却装置をつけて、水浴上で時々振り混ぜながら1時間煮沸する。温時に、これを重量既知のガラスフィルター(1G3)を用いてろ過し、残留物を温イソプロピルアルコールで洗った後に、105℃で2時間乾燥させて、ガラスフィルターの重量を測定する。次式によりアルコール不溶分を求め、これを塩化ナトリウムの含有量とする。
アルコール不溶分(%)=〔(測定後のガラスフィルター重量 − 測定前のガラスフィルター重量)/サンプル重量〕×100
The content of sodium chloride contained in the surfactant composition can be measured by, for example, an alcohol insoluble content, and specifically, it can be measured by the following method.
First, the surfactant composition is weighed in an Erlenmeyer flask, isopropyl alcohol is added thereto, and then a reflux cooling device is attached to boil the surfactant composition for 1 hour with occasional shaking on a water bath. At warm time, this is filtered using a glass filter of known weight (1G3), the residue is washed with warm isopropyl alcohol and then dried at 105 ° C. for 2 hours to weigh the glass filter. The alcohol insoluble content is determined by the following formula, and this is used as the sodium chloride content.
Alcohol insoluble content (%) = [(Glass filter weight after measurement-Glass filter weight before measurement) / Sample weight] x 100

本発明の界面活性剤組成物は、通常の方法に従って製造することができる。例えば、塩酸の存在下でN−アシルメチルタウリン塩とタウリン塩とを反応させて、成分(A)のN−アシルメチルタウリンのタウリン塩を調製し、逆浸透膜法等の脱塩処理により組成物中に含有される塩化ナトリウムの含有量を2質量%以下に調整する。また必要に応じて、有効成分である成分(A)の含有量を調整するために、精製水で希釈、または逆浸透膜法等による濃縮を行なう。このようにして得られた、成分(A)を含有する水溶液に、所定量の成分(B)を配合することによって、本発明の界面活性剤組成物が製造される。 The surfactant composition of the present invention can be produced according to a usual method. For example, the N-acylmethyl taurine salt and the taurine salt are reacted in the presence of hydrochloric acid to prepare the taurine salt of N-acylmethyl taurine as the component (A), and the composition is formed by desalting treatment such as a back-penetration membrane method. The content of sodium chloride contained in the product is adjusted to 2% by mass or less. If necessary, in order to adjust the content of the active ingredient (A), it is diluted with purified water or concentrated by a reverse osmosis membrane method or the like. The surfactant composition of the present invention is produced by blending a predetermined amount of the component (B) with the aqueous solution containing the component (A) thus obtained.

本発明の界面活性剤組成物は、蒸留水やイオン交換水などの精製水を含有し、通常は水溶液の形態で提供される。また本発明の界面活性剤組成物は、場合により、任意成分を含有していてもよい。 The surfactant composition of the present invention contains purified water such as distilled water and ion-exchanged water, and is usually provided in the form of an aqueous solution. Further, the surfactant composition of the present invention may contain an arbitrary component as the case may be.

〔実施例1,2、参考例1〜8および比較例1〜11〕
以下、本発明を実施例および比較例により具体的に説明する。
表1および表2に記載の配合に基づいて界面活性剤組成物を調製した。各組成物の調製方法は以下のとおりである。
[Examples 1 and 2, Reference Examples 1 to 8 and Comparative Examples 1 to 11]
Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples.
Surfactant compositions were prepared based on the formulations shown in Tables 1 and 2. The preparation method of each composition is as follows.

(1)N−アシルメチルタウリン塩含有水溶液の調製
特許文献2の実施例に従って調製した。すなわち、2リットル容量の4つ口フラスコにタウリンナトリウム塩(分子量147)の50質量%水溶液308.7g(1.05モル)を仕込み、これに36質量%塩酸106.5g(1.05モル)を加え、50℃で10分間攪拌した。次いで、N−ココイルメチルタウリンナトリウム塩(分子量358.8)27質量%水溶液1329.9g(1モル)を加え、50℃で30分間攪拌してN−ココイルメチルタウリンのタウリンナトリウム塩(一般式(1)のR1COがココイル基、X中のMがナトリウムである。有効成分濃度:28質量%)水溶液を得た。この水溶液に含有される塩化ナトリウムは3.6質量%であった。
(1) Preparation of N-acylmethyltaurine salt-containing aqueous solution Prepared according to the examples of Patent Document 2. That is, 308.7 g (1.05 mol) of a 50 mass% aqueous solution of taurine sodium salt (molecular weight 147) was charged into a 2-liter volume four-necked flask, and 106.5 g (1.05 mol) of 36 mass% hydrochloric acid was charged therein. Was added, and the mixture was stirred at 50 ° C. for 10 minutes. Next, 1329.9 g (1 mol) of a 27 mass% aqueous solution of N-cocoyl methyl taurine sodium salt (molecular weight 358.8) was added, and the mixture was stirred at 50 ° C. for 30 minutes to form a taurine sodium salt of N-cocoyl methyl taurine (general formula (general formula (general formula (general formula)). 1) R 1 CO is a cocoyl group and M in X is sodium. Active ingredient concentration: 28% by mass) An aqueous solution was obtained. The sodium chloride contained in this aqueous solution was 3.6% by mass.

(2)N−アシルメチルタウリン塩含有水溶液における有効成分(成分(A))含有量および塩化ナトリウム含有量の調整
実施例1,2、参考例1〜8および比較例1〜11の各界面活性剤組成物で用いられるN−アシルメチルタウリン塩含有水溶液(以下、成分(A)水溶液ともいう。)は、上記(1)で調製したN−ココイルメチルタウリンのタウリンナトリウム塩水溶液について、ポリアミド化スルホン膜を用いた逆浸透膜法による脱塩処理を行なうことにより、N−ココイルメチルタウリンのタウリンナトリウム塩および塩化ナトリウムの各含有量を調整して得た。以下に各例の調整法を示す。
(2) Adjustment of Active Ingredient (Component (A)) Content and Sodium Chloride Content in N-Acylmethyl Taurine Salt-Containing Aqueous Solution Each surface activity of Examples 1 and 2, Reference Examples 1 to 8 and Comparative Examples 1 to 11 The N-acylmethyl taurine salt-containing aqueous solution (hereinafter, also referred to as component (A) aqueous solution) used in the agent composition is a polyamided sulfone with respect to the taurine sodium salt aqueous solution of N-cocoyl methyl taurine prepared in (1) above. It was obtained by adjusting the contents of sodium taurine and sodium chloride of N-cocoyl methyl taurine by performing desalting treatment by a reverse osmotic membrane method using a membrane. The adjustment method of each example is shown below.

参考例1およびの成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液500gから逆浸透膜処理により水を38.2g抜き、塩化ナトリウム1.4gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が30.0質量%、塩化ナトリウムの含有量が0.8質量%の水溶液を調製し、参考例1およびの成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Examples 1 and 8 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active component concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to prepare 500 g of water. When 500 g of purified water was drained and 500 g of purified water was drained again, 500 g of water was drained by reverse osmosis membrane treatment, 500 g of purified water was further added, and 500 g of water was drained by reverse osmosis membrane treatment, the content of sodium chloride was 0.6% by mass. , The content of sodium salt of taurine in N-cocoyl methyl taurine was 27.8% by mass. 38.2 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, and 1.4 g of sodium chloride was added to increase the content of sodium taurine salt of N-cocoyl methyl taurine to 30.0% by mass and the content of sodium chloride. A 0.8% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Reference Examples 1 and 8.

なお、有効成分の含有量は、乾燥残量を測定し、乾燥残量と塩化ナトリウムの含有量の差分を求め、これを有効成分の含有量とした。乾燥残量の測定法は具体的には次のとおりである。すなわち、サンプル約2gを重量既知の秤量瓶に量り、次いで105℃に設定した送風乾燥機中に2時間静置した。シリカゲルの入ったデシケータ中で30分間放冷した後に秤量し、次式により乾燥残量を求めた。
乾燥残量(%)=〔(乾燥後の秤量瓶重量 − 秤量瓶重量)/サンプル重量〕×100
As for the content of the active ingredient, the remaining amount of dryness was measured, the difference between the remaining amount of dryness and the content of sodium chloride was obtained, and this was taken as the content of the active ingredient. Specifically, the method for measuring the remaining amount of dryness is as follows. That is, about 2 g of the sample was weighed in a weighing bottle of known weight, and then allowed to stand in a blower dryer set at 105 ° C. for 2 hours. After allowing to cool in a desiccator containing silica gel for 30 minutes, the mixture was weighed and the remaining amount of drying was determined by the following formula.
Remaining dryness (%) = [(Weighing bottle weight after drying-Weighing bottle weight) / Sample weight] x 100

参考例2の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は1.1質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液100gをとり、これに精製水26.3g、塩化ナトリウム0.6gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が1.3質量%の水溶液を調製し、参考例2の成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Example 2 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to remove 500 g of water. When 500 g of purified water was added again and 500 g of water was removed by reverse osmosis membrane treatment, the content of sodium chloride was 1.1% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. there were. Take 100 g of this aqueous solution, add 26.3 g of purified water and 0.6 g of sodium chloride to it, and the content of sodium taurine salt of N-cocoyl methyl taurine is 22.0% by mass, and the content of sodium chloride is 1. A 3% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Reference Example 2.

参考例3および実施例1の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液500gから逆浸透膜処理により水を37.4g抜き、塩化ナトリウム0.5gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が30.0質量%、塩化ナトリウム含有量が0.6質量%の水溶液を調製し、参考例3および実施例1の成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Example 3 and Example 1 500 g of purified water was added to 500 g of an aqueous solution of sodium chloride of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane. 500 g of purified water was removed, 500 g of purified water was added again, 500 g of water was removed by reverse osmosis membrane treatment, 500 g of purified water was added again, and 500 g of water was removed by reverse osmosis membrane treatment. The sodium chloride content was 0.6. The content of sodium salt of taurine in N-cocoyl methyl taurine was 27.8% by mass. 37.4 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, 0.5 g of sodium chloride was added, and the content of sodium taurine salt of N-cocoyl methyl taurine was 30.0% by mass and the content of sodium chloride was 0. A 6% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Reference Example 3 and Example 1.

参考例4およびの成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は1.1質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液100gをとり、これに精製水26.7g、塩化ナトリウム0.2gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が1.0質量%の水溶液を調製し、参考例4およびの成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Examples 4 and 5 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active component concentration of 28% by mass, and this mixed solution was treated with a back-penetration membrane to prepare 500 g of water. When 500 g of purified water was removed and 500 g of water was removed by back-penetration membrane treatment, the content of sodium chloride was 1.1% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. %Met. Take 100 g of this aqueous solution, add 26.7 g of purified water and 0.2 g of sodium chloride to it, and the content of sodium taurine salt of N-cocoyl methyl taurine is 22.0% by mass, and the content of sodium chloride is 1. A 0% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Reference Examples 4 and 5.

参考例6の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらにもう一度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.3質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液500gから逆浸透膜処理により水を38.2g抜き、塩化ナトリウム0.9gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が30.0質量%、塩化ナトリウムの含有量が0.4質量%の水溶液を調製し、参考例6の成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Example 6 500 g of purified water was added to 500 g of a taurine sodium salt aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to remove 500 g of water. Add 500 g of purified water again, remove 500 g of water by reverse osmosis membrane treatment, add 500 g of purified water again, remove 500 g of water by reverse osmosis membrane treatment, add 500 g of purified water again, and add water by reverse osmosis membrane treatment. When 500 g was removed, the content of sodium chloride was 0.3% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.8% by mass. 38.2 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, and 0.9 g of sodium chloride was added to increase the content of sodium taurine salt of N-cocoyl methyl taurine to 30.0% by mass and the content of sodium chloride. A 0.4% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Reference Example 6.

実施例の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液100gをとり、これに精製水25.9g、塩化ナトリウム0.4gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が0.8質量%の水溶液を調製し、実施例の成分(A)水溶液とした。
Aqueous solution of component (A) of Example 2 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, this mixed solution was treated with a reverse osmosis membrane, and 500 g of water was removed. When 500 g of purified water was added again, 500 g of water was removed by reverse osmosis membrane treatment, 500 g of purified water was added again, and 500 g of water was removed by reverse osmosis membrane treatment, the sodium chloride content was 0.6% by mass, N. -The content of sodium taurine salt of cocoyl methyl taurine was 27.8% by mass. Taking 100 g of this aqueous solution, 25.9 g of purified water and 0.4 g of sodium chloride were added thereto, and the content of sodium taurine salt of N-cocoyl methyl taurine was 22.0% by mass, and the content of sodium chloride was 0. An 8% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Example 2.

参考例7の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜いたところ、塩化ナトリウムの含有量は2.0質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液100gをとり、これに精製水54.6g加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が18.0質量%、塩化ナトリウムの含有量が1.3質量%の水溶液を調製し、参考例7の成分(A)水溶液とした。
Aqueous solution of component (A) of Reference Example 7 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a back-penetration membrane to remove 500 g of water. However, the content of sodium chloride was 2.0% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. Take 100 g of this aqueous solution and add 54.6 g of purified water to prepare an aqueous solution containing 18.0% by mass of sodium taurine salt of N-cocoyl methyl taurine and 1.3% by mass of sodium chloride. Then, the component (A) aqueous solution of Reference Example 7 was used.

比較例1の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液500gから逆浸透膜処理により水を38.2g抜き、塩化ナトリウム1.4gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が30.0質量%、塩化ナトリウムの含有量が0.8質量%の水溶液を調製し、比較例1の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Example 1 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to remove 500 g of water. When 500 g of purified water was added again, 500 g of water was removed by reverse osmosis membrane treatment, 500 g of purified water was added again, and 500 g of water was removed by reverse osmosis membrane treatment, the sodium chloride content was 0.6% by mass, N. -The content of sodium taurine salt of cocoyl methyl taurine was 27.8% by mass. 38.2 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, and 1.4 g of sodium chloride was added to increase the content of sodium taurine salt of N-cocoyl methyl taurine to 30.0% by mass and the content of sodium chloride. A 0.8 mass% aqueous solution was prepared and used as the component (A) aqueous solution of Comparative Example 1.

比較例2の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は1.1質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液100gをとり、これに精製水26.3g、塩化ナトリウム0.6gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が1.3質量%の水溶液を調製し、比較例2の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Example 2 500 g of purified water was added to 500 g of an aqueous solution of sodium chloride of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to remove 500 g of water. When 500 g of purified water was added again and 500 g of water was removed by reverse osmosis membrane treatment, the content of sodium chloride was 1.1% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. there were. Take 100 g of this aqueous solution, add 26.3 g of purified water and 0.6 g of sodium chloride to it, and the content of sodium taurine salt of N-cocoyl methyl taurine is 22.0% by mass, and the content of sodium chloride is 1. A 3% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Comparative Example 2.

比較例3の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液500gから逆浸透膜処理により水を152.5g抜き、塩化ナトリウム0.4gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が40.0質量%、塩化ナトリウムの含有量が0.5質量%の水溶液を調製し、比較例3の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Example 3 500 g of purified water was added to 500 g of an aqueous solution of sodium chloride of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane to remove 500 g of water. When 500 g of purified water was added again, 500 g of water was removed by reverse osmosis membrane treatment, 500 g of purified water was added again, and 500 g of water was removed by reverse osmosis membrane treatment, the sodium chloride content was 0.6% by mass, N. -The content of sodium taurine salt of cocoyl methyl taurine was 27.8% by mass. 152.5 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, and 0.4 g of sodium chloride was added to increase the content of sodium taurine salt of N-cocoyl methyl taurine to 40.0% by mass and the content of sodium chloride. An aqueous solution of 0.5% by mass was prepared and used as an aqueous solution of component (A) of Comparative Example 3.

比較例4および比較例7〜11の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜き、もう一度精製水500gを加え、逆浸透膜処理により水を500g抜き、さらに再度精製水500gを加え、逆浸透膜処理により水を500g抜いたところ、塩化ナトリウムの含有量は0.6質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.8質量%であった。この水溶液100gをとり、これに精製水25.9g、塩化ナトリウム0.4gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が0.8質量%の水溶液を調製し、比較例4および比較例7〜11の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Examples 4 and 7 to 11 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active ingredient concentration of 28% by mass, and this mixed solution was treated with a reverse osmosis membrane. , 500 g of water was drained, 500 g of purified water was added again, 500 g of water was drained by reverse osmosis membrane treatment, 500 g of purified water was further added, and 500 g of water was drained by reverse osmosis membrane treatment. The sodium chloride content was 0. The content of sodium taurine salt of N-cocoyl methyl taurine was .6% by mass and was 27.8% by mass. Taking 100 g of this aqueous solution, 25.9 g of purified water and 0.4 g of sodium chloride were added thereto, and the content of sodium taurine salt of N-cocoyl methyl taurine was 22.0% by mass, and the content of sodium chloride was 0. An 8% by mass aqueous solution was prepared and used as an aqueous solution of component (A) of Comparative Examples 4 and 7-11.

比較例5の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜いたところ、塩化ナトリウムの含有量は2.0質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液100gをとり、これに精製水25.6g、塩化ナトリウム1.2gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が22.0質量%、塩化ナトリウムの含有量が2.5質量%の水溶液を調製し、比較例5の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Example 5 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active component concentration of 28% by mass, and this mixed solution was treated with a back-penetration membrane to remove 500 g of water. However, the content of sodium chloride was 2.0% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. Take 100 g of this aqueous solution, add 25.6 g of purified water and 1.2 g of sodium chloride to it, and the content of sodium taurine salt of N-cocoyl methyl taurine is 22.0% by mass, and the content of sodium chloride is 2. A 5% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Comparative Example 5.

比較例6の成分(A)水溶液
有効成分濃度28質量%のN−ココイルメチルタウリンのタウリンナトリウム塩水溶液500gに精製水500gを加え、この混合液を逆浸透膜で処理し、水を500g抜いたところ、塩化ナトリウムの含有量は2.0質量%、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量は27.9質量%であった。この水溶液500gから逆浸透膜処理により水を38.1g抜き、塩化ナトリウム2.8gを加えて、N−ココイルメチルタウリンのタウリンナトリウム塩の含有量が30.0質量%、塩化ナトリウムの含有量が2.5質量%の水溶液を調製し、比較例6の成分(A)水溶液とした。
Aqueous solution of component (A) of Comparative Example 6 500 g of purified water was added to 500 g of a sodium chloride aqueous solution of N-cocoyl methyl taurine having an active component concentration of 28% by mass, and this mixed solution was treated with a back-penetration membrane to remove 500 g of water. However, the content of sodium chloride was 2.0% by mass, and the content of sodium taurine salt of N-cocoyl methyl taurine was 27.9% by mass. 38.1 g of water was removed from 500 g of this aqueous solution by back-penetration membrane treatment, and 2.8 g of sodium chloride was added to increase the content of sodium chloride in N-cocoyl methyl taurine to 30.0% by mass and the content of sodium chloride. A 2.5% by mass aqueous solution was prepared and used as the component (A) aqueous solution of Comparative Example 6.

(3)成分(B)の配合
成分(B)の各有機酸を各組成物に必要な含有量となるように、上記(2)で得た水溶液に配合して、実施例1,2、参考例1〜8および比較例1〜11の各界面活性剤組成物を調製した。
(3) Formulation of component (B) Each organic acid of component (B) is blended with the aqueous solution obtained in (2) above so as to have a required content in each composition, and Examples 1 and 2 and The surfactant compositions of Reference Examples 1 to 8 and Comparative Examples 1 to 11 were prepared.

次に、下記の方法で、各組成物の室温での外観、および低温からの復元性を評価した。その結果を表1、2に示す。表中の数値は純分の質量%を示す。 Next, the appearance of each composition at room temperature and the resilience from low temperature were evaluated by the following methods. The results are shown in Tables 1 and 2. The numerical values in the table indicate the mass% of the pure content.

A.室温での外観
各組成物100gを60℃で透明均一に溶解したのち200ml容量のガラス瓶に入れ、蓋をした状態で20℃の恒温槽に24時間保存した。24時間後の各組成物の外観について、下記2段階の基準で肉眼にて評価した。
A. Appearance at Room Temperature 100 g of each composition was transparently and uniformly dissolved at 60 ° C., then placed in a glass bottle having a capacity of 200 ml, and stored in a constant temperature bath at 20 ° C. for 24 hours with the lid closed. The appearance of each composition after 24 hours was visually evaluated according to the following two-step criteria.

(室温での外観)
(評点):(評価)
○:組成物が透明である。
×:組成物に分離または固化が見られる。
(Appearance at room temperature)
(Score): (Evaluation)
◯: The composition is transparent.
X: Separation or solidification is observed in the composition.

B.低温固化からの復元性
各組成物100gを60℃で透明均一に溶解したのち200ml容量のガラス瓶に入れ、−5℃の恒温槽に24時間保存して固化させた。その後、20℃の恒温槽に24時間保存した。24時間後の20℃の恒温槽内での各組成物の外観について、下記2段階の基準で肉眼にて評価した。
B. Restorability from low-temperature solidification 100 g of each composition was transparently and uniformly dissolved at 60 ° C., then placed in a glass bottle having a capacity of 200 ml and stored in a constant temperature bath at −5 ° C. for 24 hours for solidification. Then, it was stored in a constant temperature bath at 20 ° C. for 24 hours. The appearance of each composition in a constant temperature bath at 20 ° C. after 24 hours was visually evaluated according to the following two-step criteria.

(低温固化からの復元性)
(評点):(評価)
○:組成物が透明である。
×:組成物に分離または固化が見られる。
(Restorability from low temperature solidification)
(Score): (Evaluation)
◯: The composition is transparent.
X: Separation or solidification is observed in the composition.

Figure 0006834376
Figure 0006834376

Figure 0006834376
Figure 0006834376

実施例1,2より、本発明の界面活性剤組成物は、いずれの組成物においても室温での外観が透明であり、低温固化からの復元性も良好であった。 From Examples 1 and 2 , the surfactant composition of the present invention had a transparent appearance at room temperature and good resilience from low-temperature solidification in any of the compositions.

一方、比較例1〜11では十分な効果が得られていない。
比較例1および2では、成分(B)のヒドロキシ酸またはジカルボン酸が含有されていないため、室温で透明にならず、低温固化からの復元性が認められない。
比較例3では、成分(A)のN−アシルメチルタウリンのタウリン塩の含有量が35質量%を超えているため、室温で透明にならず、低温固化からの復元性が認められない。
比較例4では、成分(B)のヒドロキシ酸またはジカルボン酸の含有量が5質量%を超えているため、室温では透明であるが、低温固化からの復元性が認められない。
比較例5および6では、塩化ナトリウムの含有量が2質量%を超えているため、室温で透明にならず、低温固化からの復元性が認められない。
比較例7では、成分(B)のヒドロキシ酸またはジカルボン酸の代わりに1,3−ブチレングリコールを使用しているため、室温では透明であるが、低温固化からの復元性が認められない。
比較例8では、成分(B)のヒドロキシ酸またはジカルボン酸の代わりにグリセリンを使用しているため、室温で透明にならず、低温固化からの復元性が認められない。
比較例9では、成分(B)のヒドロキシ酸またはジカルボン酸の代わりにポリエチレングリコールを使用しているため、室温で透明にならず、低温固化からの復元性が認められない。
比較例10では、成分(B)のヒドロキシ酸またはジカルボン酸の代わりにエタノールを使用しているため、室温で透明にならず、低温固化からの復元性が認められない。
比較例11では、成分(B)のヒドロキシ酸またはジカルボン酸の代わりに2−エチルヘキサノールを使用しているため、室温で透明にならず、低温固化からの復元性が認められない。
On the other hand, in Comparative Examples 1 to 11, sufficient effects were not obtained.
In Comparative Examples 1 and 2, since the hydroxy acid or dicarboxylic acid of the component (B) is not contained, the substance (B) is not transparent at room temperature and is not recoverable from low temperature solidification.
In Comparative Example 3, since the content of the taurine salt of N-acylmethyltaurine of the component (A) exceeds 35% by mass, it does not become transparent at room temperature, and restoration from low temperature solidification is not observed.
In Comparative Example 4, since the content of the hydroxy acid or dicarboxylic acid of the component (B) exceeds 5% by mass, it is transparent at room temperature, but no resilience from low temperature solidification is observed.
In Comparative Examples 5 and 6, since the content of sodium chloride exceeds 2% by mass, it does not become transparent at room temperature, and recovery from low temperature solidification is not observed.
In Comparative Example 7, since 1,3-butylene glycol is used instead of the hydroxy acid or dicarboxylic acid of the component (B), it is transparent at room temperature, but no resilience from low temperature solidification is observed.
In Comparative Example 8, since glycerin is used instead of the hydroxy acid or dicarboxylic acid of the component (B), it does not become transparent at room temperature, and recovery from low temperature solidification is not observed.
In Comparative Example 9, since polyethylene glycol is used instead of the hydroxy acid or dicarboxylic acid of the component (B), it does not become transparent at room temperature, and recovery from low temperature solidification is not observed.
In Comparative Example 10, since ethanol is used instead of the hydroxy acid or dicarboxylic acid of the component (B), it does not become transparent at room temperature, and recovery from low temperature solidification is not observed.
In Comparative Example 11, since 2-ethylhexanol is used in place of the hydroxy acid or dicarboxylic acid of the component (B), it does not become transparent at room temperature, and recovery from low temperature solidification is not observed.

本発明の界面活性剤組成物は、化粧料や医薬品等の製剤の原料として好適に利用することができ、例えば、頭皮、頭髪やボディ用洗浄剤といった身体用洗浄剤の主成分または補助成分として利用することができる。

The surfactant composition of the present invention can be suitably used as a raw material for preparations such as cosmetics and pharmaceuticals, and can be used as a main component or an auxiliary component of a body cleanser such as a scalp, hair or body cleanser, for example. It can be used.

Claims (1)

(A)下記一般式(1)で示されるN−アシルメチルタウリンのタウリン塩を15〜35質量%、(B)炭素数6以下のジカルボン酸を0.5〜5質量%含有し、塩化ナトリウムの含有量が2質量%以下であることを特徴とする界面活性剤組成物。
CON(CH)CHCHSO ・・・(1)
(RCOは炭素数8〜24のアシル基、XはHCHCHSO であり、Mはアルカリ金属イオンまたは有機アンモニウムである。)
(A) 15 to 35 wt% taurine salt of N--acylmethyltaurine represented by the following general formula (1) contains 0.5 to 5 wt% of (B) having 6 or less of dicarboxylic acid carbon, chloride A surfactant composition having a sodium content of 2% by mass or less.
R 1 CON (CH 3 ) CH 2 CH 2 SO 3 - X + ... (1)
(R 1 CO is an acyl group having 8 to 24 carbon atoms, X + is H 3 N + CH 2 CH 2 SO 3 - M + , and M + is an alkali metal ion or organic ammonium.)
JP2016219392A 2015-11-17 2016-11-10 Surfactant composition Active JP6834376B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015225213 2015-11-17
JP2015225213 2015-11-17

Publications (2)

Publication Number Publication Date
JP2017095451A JP2017095451A (en) 2017-06-01
JP6834376B2 true JP6834376B2 (en) 2021-02-24

Family

ID=58803691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016219392A Active JP6834376B2 (en) 2015-11-17 2016-11-10 Surfactant composition

Country Status (2)

Country Link
JP (1) JP6834376B2 (en)
CN (1) CN106860035B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3288520A4 (en) 2015-05-01 2018-12-12 L'oreal Use of active agents during chemical treatments
JP6758377B2 (en) 2015-11-24 2020-09-23 ロレアル Composition for treating hair
CN108495687B (en) 2015-11-24 2021-11-09 欧莱雅 Composition for treating hair
CN108495686A (en) 2015-11-24 2018-09-04 欧莱雅 Composition for handling hair
US11135150B2 (en) 2016-11-21 2021-10-05 L'oreal Compositions and methods for improving the quality of chemically treated hair
US9974725B1 (en) 2017-05-24 2018-05-22 L'oreal Methods for treating chemically relaxed hair
ES2914404T3 (en) 2017-12-29 2022-06-10 Oreal Compositions for altering hair color
JP7415417B2 (en) * 2018-10-19 2024-01-17 大正製薬株式会社 cleaning composition
US11090249B2 (en) 2018-10-31 2021-08-17 L'oreal Hair treatment compositions, methods, and kits for treating hair
US11419809B2 (en) 2019-06-27 2022-08-23 L'oreal Hair treatment compositions and methods for treating hair
JP7467105B2 (en) * 2019-12-24 2024-04-15 クラシエ株式会社 Cleaning composition
CN113801039B (en) * 2020-06-12 2023-07-11 万华化学集团股份有限公司 Method for preparing N-methyl sodium taurate
CN113620845B (en) * 2021-08-10 2023-01-13 万华化学集团股份有限公司 Humectant and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001181675A (en) * 1999-12-24 2001-07-03 Nof Corp Detergent composition
JP4025950B2 (en) * 2000-04-28 2007-12-26 ライオン株式会社 Bactericidal compound-containing composition
JP4916626B2 (en) * 2001-08-01 2012-04-18 株式会社 資生堂 Cleaning composition
JP3801090B2 (en) * 2002-03-28 2006-07-26 東邦化学工業株式会社 Surfactant manufacturing method
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
CN101496777B (en) * 2008-01-30 2014-07-02 株式会社资生堂 Oil in water type emulsification cosmetic
JP2010159234A (en) * 2009-01-09 2010-07-22 Shiseido Co Ltd Hair detergent

Also Published As

Publication number Publication date
CN106860035B (en) 2021-06-11
CN106860035A (en) 2017-06-20
JP2017095451A (en) 2017-06-01

Similar Documents

Publication Publication Date Title
JP6834376B2 (en) Surfactant composition
US7867961B2 (en) Wash composition
US10172774B2 (en) Use of N-methyl-N-acylglucamines as thickening agents in surfactant solutions
JP4644493B2 (en) Surfactant composition and detergent composition and emulsified composition using the same
JP2005089752A (en) Oxyalkylated polyglycerol ester-containing liquid composition
TWI604857B (en) Detergent composition
CN102836086A (en) Thickening/foam boosting agent
TWI605831B (en) Detergent composition
WO2001027229A1 (en) Detergent composition
JPWO2005032509A1 (en) Cleaning composition
JP2005272788A (en) Surfactant composition
JP6103210B2 (en) Skin cleanser composition
JP2014062226A (en) Thickener composition
BR112015020311B1 (en) SKIN CLEANSING COMPOSITION, CLEANING COMPOSITION, AND, SCARF
JP4173962B2 (en) Detergent composition with pearly luster and pearly luster concentrate with good dispersibility
JP6957208B2 (en) Surfactant composition
JP5191026B2 (en) Cleaning composition
JP7052221B2 (en) Detergent composition
JP4030746B2 (en) Pearl luster imparting agent
JP6654990B2 (en) Liquid skin cleanser composition
JP2021155387A (en) Cosmetic
JP2007119437A (en) Gommage cosmetic
JPS6258399B2 (en)
JP2002348219A (en) Detergent composition
JP2005060235A (en) Skin cleaning agent

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20161206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190708

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200727

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201111

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20201111

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201119

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210118

R150 Certificate of patent or registration of utility model

Ref document number: 6834376

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250